NEW YORK, Jan. 21, 2020 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company focused on developing new generation therapies for dermatological and immunological ...
Hoth Therapeutics Inc (NASDAQ:HOTH) has agreed to license its cannabinoid therapeutic, HT-005, for lupus patients back to Zylö Therapeutics. What Happened: In August 2019, Hoth Therapeutics and Zylö ...
NEW YORK, April 24, 2020 /PRNewswire/ -- Hoth Therapeutics, Inc. (Nasdaq: HOTH) announced today that Voltron Therapeutics, Inc has selected the peptides required to complete the structure of HaloVax ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback